aztreonam has been researched along with Burns in 6 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This research focuses on the feasibility of using silver- and fluoride-containing BGs against multidrug-resistant bacterial strains isolated from patients with burns." | 7.83 | Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. ( Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F, 2016) |
| " This research focuses on the feasibility of using silver- and fluoride-containing BGs against multidrug-resistant bacterial strains isolated from patients with burns." | 3.83 | Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. ( Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F, 2016) |
| " No significant differences in any pharmacokinetic parameters between first dose and steady state were observed." | 2.67 | Aztreonam pharmacokinetics in burn patients. ( Brundage, DM; Friedrich, LV; Kays, MB; White, RL; Yarbrough, D, 1991) |
| "aeruginosa burn wound infection, aztreonam and piperacillin should be considered as the first line of defense." | 1.30 | The use of aztreonam as an alternate therapy for multi-resistant Pseudomonas aeruginosa. ( Heggers, JP; Herndon, DN; Villarreal, C; Walton, MA, 1997) |
| "To assess the impact of degradation of aztreonam, a beta-lactam antibiotic, during HPLC analysis on pharmacokinetic parameter estimates." | 1.29 | Drug degradation during HPLC analysis of aztreonam: effect on pharmacokinetic parameter estimation. ( Burgess, DS; Friedrich, LV; Kays, MB; White, RL, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gholipourmalekabadi, M | 1 |
| Sameni, M | 1 |
| Hashemi, A | 1 |
| Zamani, F | 1 |
| Rostami, A | 1 |
| Mozafari, M | 1 |
| Friedrich, LV | 2 |
| White, RL | 2 |
| Kays, MB | 2 |
| Burgess, DS | 1 |
| Walton, MA | 1 |
| Villarreal, C | 1 |
| Herndon, DN | 1 |
| Heggers, JP | 1 |
| Brundage, DM | 1 |
| Yarbrough, D | 1 |
| Fasano, D | 1 |
| Palù, P | 1 |
| Papadia, F | 1 |
| Manson, WL | 1 |
| Dijkema, H | 1 |
| Klasen, HJ | 1 |
1 trial available for aztreonam and Burns
| Article | Year |
|---|---|
Aztreonam pharmacokinetics in burn patients.
Topics: Adolescent; Adult; Aged; Aztreonam; Burns; Dose-Response Relationship, Drug; Female; Humans; Kidney; | 1991 |
5 other studies available for aztreonam and Burns
| Article | Year |
|---|---|
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ce | 2016 |
Drug degradation during HPLC analysis of aztreonam: effect on pharmacokinetic parameter estimation.
Topics: Aztreonam; Burns; Chromatography, High Pressure Liquid; Drug Stability; Humans; Random Allocation | 1994 |
The use of aztreonam as an alternate therapy for multi-resistant Pseudomonas aeruginosa.
Topics: Aminoglycosides; Aztreonam; Burns; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Thera | 1997 |
[Use of aztreonam in the perioperative prevention in burned patients].
Topics: Aztreonam; Burns; Drug Evaluation; Drug Therapy, Combination; Humans; Oxacillin; Premedication; Skin | 1990 |
Alteration of wound colonization by selective intestinal decontamination in thermally injured mice.
Topics: Animals; Aztreonam; Bacitracin; Burns; Cells, Cultured; Digestive System; Enterobacteriaceae; Mice; | 1990 |